Log In
BCIQ
Print this Print this
 

MSPrecise CSF Assay

  Manage Alerts
Collapse Summary General Information
Company Avant Diagnostics Inc.
DescriptionNext-generation DNA sequencing assay that measures mutations found in rearranged immunoglobulin genes in B cells isolated from cerebrospinal fluid (CSF)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationNeurology, Diagnostic
Indication DetailsDetermine risk of developing multiple sclerosis (MS); Determine the risk of developing relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$39.7M

0

$5.2M


 Deals Details
Get a free BioCentury trial today